Amicus Therapeutics (FOLD) Misses Q1 EPS by 14c
Amicus Therapeutics (NASDAQ: FOLD) reported Q1 EPS of ($0.35), $0.14 worse than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.
Amicus Therapeutics (NASDAQ: FOLD) reported Q1 EPS of ($0.35), $0.14 worse than the analyst estimate of ($0.21).
For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.